Finance

Lists
MRK:ETR
Merck KGaA
€ 137.85
+1.58%
(+2.15) 1D
10-р сарын 9, 17:39:06 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
€ 136.95
High
€ 138.75
Low
€ 136.90
Mkt. cap
17.70 тэрбум
Avg. vol.
293.97 мян
Volume
0.00
Dividend
1.60%
Quarterly dividend
€ 0.55
Ex-dividend date
2026 оны 4-р сарын 27
P/E ratio
25.28
52-wk high
€ 148.80
52-wk low
€ 100.70
EPS
€ 5.45
Shares outstanding
129.24 сая
No. of employees
62 мян
Open
€ 136.95
High
€ 138.75
Low
€ 136.90
Mkt. cap
17.70 тэрбум
Avg. vol.
293.97 мян
Volume
0.00
Dividend
1.60%
Quarterly dividend
€ 0.55
Ex-dividend date
2026 оны 4-р сарын 27
P/E ratio
25.28
52-wk high
€ 148.80
52-wk low
€ 100.70
EPS
€ 5.45
Shares outstanding
129.24 сая
No. of employees
62 мян
News stories
From web sources and news partners
Profile
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Shizuoka and Beijing, as well as other Research and Development units in Taiwan, France, Israel, South Korea, India, and the UK. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine. Merck was privately owned until going public on the Frankfurt Stock Exchange in 1995 and is listed on the DAX index of Germany's top companies. The Merck family still controls a majority of 70.3% of the company's shares. Wikipedia
About Merck KGaA
CEO-
Employees62.1 мян
Founded1668
Headquarters-
SectorPharmaceutical industry
Last report
2026 оны 8-р сарын 6
Fiscal period
Q2 2026
€ 2.16 / € 2.05
+5.32%beat
Revenue / Est. (EUR)
5.43 тэрбум / 5.30 тэрбум
+2.44%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
5.32 тэрбум
5.25 тэрбум
5.13 тэрбум
5.43 тэрбум
Cost of goods sold
2.10 тэрбум
2.20 тэрбум
2.07 тэрбум
2.27 тэрбум
Cost of revenue
2.10 тэрбум
2.20 тэрбум
2.07 тэрбум
2.27 тэрбум
Research and development expenses
660.00 сая
634.00 сая
657.70 сая
684.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.46 тэрбум
1.54 тэрбум
1.52 тэрбум
1.56 тэрбум
Operating expense
1.99 тэрбум
2.12 тэрбум
2.13 тэрбум
2.41 тэрбум
Total operating expenses
4.10 тэрбум
4.32 тэрбум
4.20 тэрбум
4.68 тэрбум
Operating income
1.22 тэрбум
926.00 сая
935.40 сая
753.00 сая
Other non operating income
1.00 сая
4.00 сая
-100.00 мян
-1.00 сая
EBT including unusual items
1.12 тэрбум
401.00 сая
868.70 сая
640.00 сая
EBT excluding unusual items
1.12 тэрбум
1.10 тэрбум
867.50 сая
640.00 сая
Income tax expense
225.00 сая
77.00 сая
200.00 сая
146.00 сая
Effective tax rate
20.04%
19.20%
23.02%
22.81%
Other operating expenses
-128.00 сая
-50.00 сая
-45.40 сая
164.00 сая
Net income
902.00 сая
319.00 сая
659.40 сая
490.00 сая
Net profit margin
16.96%
6.08%
12.84%
9.02%
Earnings per share
-
-
-
2.16
Interest and investment income
27.00 сая
21.00 сая
21.20 сая
25.00 сая
Interest expense
-126.00 сая
-43.00 сая
-80.60 сая
-137.00 сая
Net interest expenses
-99.00 сая
-22.00 сая
-59.40 сая
-112.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.68 тэрбум
1.31 тэрбум
1.42 тэрбум
1.25 тэрбум
Gain or loss from assets sale
-174.00 сая
6.00 сая
-41.90 сая
1.00 сая
AI content may include mistakes. Learn more
Google аппс